Physician profile
Susan E Robotti
NPI 1598253726
$3,954.40
in general payments reported to CMS, 2019-2025
12 companies · $1,452 in 2025
The $1,452 reported for 2025 was more than what 87% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $316 · 2022: $386 · 2023: $739 · 2024: $1,061 · 2025: $1,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,204 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,203.81 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,330.92 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $846.93 | 2021-2025 | Caplyta |
| Incyte Corporation | $384.76 | 2022-2023 | Opzelura |
| Corium, LLC | $249.99 | 2022-2023 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $249.91 | 2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Axsome Therapeutics, INC. | $244.70 | 2024-2025 | Auvelity |
| Alkermes, INC. | $225.68 | 2024-2025 | Lybalvi |
| E.R. Squibb & Sons, L.L.C. | $123.19 | 2025 | Cobenfy |
| Teva Pharmaceuticals USA, INC. | $114.62 | 2023 | Austedo Xr |
| Janssen Pharmaceuticals, INC | $83.86 | 2025 | Spravato |
| Neurelis, INC. | $83.75 | 2024 | Valtoco |
| Lundbeck LLC | $16.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Robotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.